Therapeutic approach guided by genetic alteration: use of MTOR inhibitor in renal medullary carcinoma with loss of PTEN expression

Jacob S. Lipkin, Syed M. Rizvi, Zoran Gatalica, Nabeel E. Sarwani, Sheldon L. Holder, Mathew Kaag, Joseph J. Drabick, Monika Joshi

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint Dive into the research topics of 'Therapeutic approach guided by genetic alteration: use of MTOR inhibitor in renal medullary carcinoma with loss of PTEN expression'. Together they form a unique fingerprint.

Medicine & Life Sciences